Population pharmacokinetics of vancomycin in serum and cerebrospinal fluid: variability in cerebrospinal fluid concentrations despite targeted serum exposure
Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)
DOI: 10.1128/aac.00569-26 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von Lucie Polášková und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Military University Hospital Prague, Prague, Czech Republic. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Univerzita Karlova v Praze, Ministerstvo Zdravotnictví Ceské Republiky.
Abstract (Originalsprache)
Vancomycin is a key component of empirical therapy for central nervous system (CNS) infections, yet dosing is guided by systemic pharmacokinetic/pharmacodynamic (PK/PD) targets that may not reflect drug exposure at the site of infection. Cerebrospinal fluid (CSF) penetration is variable, and the relationship between serum and CSF concentrations remains poorly defined. This study aimed to develop a population pharmacokinetic model simultaneously describing vancomycin concentrations in serum and CSF using real-world therapeutic drug monitoring (TDM) data and to characterize the relationship between systemic and CSF exposure. A retrospective observational study was conducted in adult neurosurgical patients ( n = 64) with secondary meningitis. Vancomycin concentrations in serum ( n = 133) and CSF ( n = 100) were analyzed using nonlinear mixed-effects modeling. Monte Carlo simulations were performed to evaluate exposure across dosing regimens and renal function strata. Additional simulations under targeted serum exposure (AUC 24 ~500 mg·h/L) with minimized interindividual variability in clearance were used to isolate variability in CSF exposure. A two-compartment model with a CSF compartment adequately described the data. Clearance was significantly associated with the estimated glomerular filtration rate. The median CSF-to-serum AUC ratio was 0.29, with substantial interindividual variability. Simulations demonstrated that, despite consistent serum exposure, CSF concentrations remained highly variable, with median (5 th -95 th percentile) average CSF concentrations of 6.2 (3.2–10.4) mg/L. The probability of achieving higher CSF concentration thresholds declined markedly with increasing targets. Vancomycin CSF exposure exhibits substantial variability that is not reliably predicted by serum pharmacokinetics, even under standardized systemic exposure. These findings highlight limitations of serum-guided dosing for CNS infections and support the need for compartment-specific dosing strategies and PK/PD targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Military University Hospital Prague, Prague, Czech Republic.
- Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital Prague, Prague, Czech Republic.
- Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
ORCID-Profile: Martin Šíma
Förderung
- Univerzita Karlova v Praze
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Polášková, L., Moravec, T., Krejčí, V., Netuka, D., Slanař, O., & Šíma, M. (2026). Population pharmacokinetics of vancomycin in serum and cerebrospinal fluid: variability in cerebrospinal fluid concentrations despite targeted serum exposure. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.00569-26
Vancouver
Polášková L, Moravec T, Krejčí V, Netuka D, Slanař O, Šíma M. Population pharmacokinetics of vancomycin in serum and cerebrospinal fluid: variability in cerebrospinal fluid concentrations despite targeted serum exposure. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.00569-26
BibTeX
@article{Polkov2026,
author = {Polášková, Lucie and Moravec, Tomáš and Krejčí, Veronika and Netuka, David and Slanař, Ondřej and Šíma, Martin},
title = {Population pharmacokinetics of vancomycin in serum and cerebrospinal fluid: variability in cerebrospinal fluid concentrations despite targeted serum exposure},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {8},
doi = {10.1128/aac.00569-26}
}
EUVIMED